Back to companies

Lyra Therapeutics Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Lyra Therapeutics Inc (Lyra Therapeutics) is a clinical-stage biotechnology company. The company focuses on developing anti-inflammatory nasal inserts for the treatment of chronic rhinosinusitis (CRS). The company offers XTreo platform for the delivery of medicines. Its pipeline products include LYR-210, designed for chronic rhinosinusitis patients with nasal polyps, and LYR-220, aimed at treating patients with post-surgical anatomy. The company's products are used by healthcare providers to treat patients suffering from chronic rhinosinusitis. Lyra Therapeutics is headquartered in Watertown, Massachusetts, the US.

 Gain a 360-degree view of Lyra Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Lyra Therapeutics Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 480 Arsenal Way, Watertown, Massachusetts, 02472
Website lyratherapeutics.com
Telephone 1 617 3934600
No of Employees 30
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange LYRA (NASD)
Revenue (2024) $1.5M -1.5% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ -49.1% (2024 vs 2023)
Market Cap* $440,000
Net Profit Margin (2024) XYZ -51.4% (2024 vs 2023)
* As of and is in US$
View Lyra Therapeutics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Products and Services

Products Brands
Pipeline XTreo
LYR-210: Chronic Rhinosinusitis Patients with Nasal Polyps
LYR-220: Chronic Rhinosinusitis Patients with Post-Surgical Anatomy
XYZ
XYZ
XYZ
Understand Lyra Therapeutics Inc portfolio and identify potential areas for collaboration Understand Lyra Therapeutics Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Lyra Therapeutics Inc Insmed Inc OptiNose Inc Synedgen Inc
Headquarters United States of America United States of America United States of America United States of America
City Watertown Bridgewater Yardley Claremont
State/Province Massachusetts New Jersey Pennsylvania California
No. of Employees 30 1,271 127 -
Entity Type Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Maria Palasis, Ph.D. Chief Executive Officer; Director; President Executive Board - 60
Jason Cavalier Chief Financial Officer Senior Management - 52
Ronan O'Brien Chief Legal Officer Senior Management - -
Vineeta Belanger, Ph.D. Senior Vice President - Clinical Affairs Senior Management - -
Allison Nance Senior Vice President - Regulatory Affairs Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Lyra Therapeutics Inc key executives to enhance your sales strategy Gain insight into Lyra Therapeutics Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?